Download Concise Guide to Child and Adolescent Psychiatry, Third Edition (Concise Guides) PDF

TitleConcise Guide to Child and Adolescent Psychiatry, Third Edition (Concise Guides)
Author
LanguageEnglish
File Size1.8 MB
Total Pages407
Table of Contents
                            Contents
About the Authors
Introduction to the Concise Guides Series
Preface to the Third Edition
1 Introduction
	Change in Children and Adolescents
	Overview of Diagnosis
		Use of DSM-IV-TR for Children and Adolescents
		Comorbidity
	Overview of Treatment
	References
	Additional Reading
2 Evaluation and Treatment Planning
	Evaluation
		Use of Multiple Informants
		History From Parents
		Patient Interview
		Family Evaluation
		Standardized Evaluation Instruments
		Medical Evaluation
		School Assessment
		Psychological Testing
	Treatment Planning
	Feedback
	Additional Reading
3 Axis I Disorders Usually First Diagnosed in Infancy, Childhood, or Adolescence: Attention-Deficit and Disruptive Behavior Disorders
	Attention-Deficit/Hyperactivity Disorder
		Clinical Description
		Epidemiology
		Comorbidity
		Etiology
		Course and Prognosis
		Evaluation
		Differential Diagnosis
		Monitoring Treatment
		Treatment
	Conduct Disorder
		Clinical Description
		Epidemiology
		Comorbidity
		Etiology
		Course and Prognosis
		Evaluation
		Differential Diagnosis
		Treatment
	Oppositional Defiant Disorder
		Clinical Description
		Epidemiology
		Etiology
		Course and Prognosis
		Evaluation and Differential Diagnosis
		Treatment
	References
	Additional Reading
4 Other Axis I Disorders Usually First Diagnosed in Infancy, Childhood, or Adolescence
	Separation Anxiety Disorder
		Clinical Description
		Epidemiology
		Etiology
		Course and Prognosis
		Evaluation and Differential Diagnosis
		Treatment
	Feeding and Eating Disorders of Infancy or Early Childhood
		Pica
		Rumination Disorder of Infancy
	Tourette's Disorder and Other Tic Disorders
		Clinical Description
		Epidemiology
		Comorbidity
		Etiology
		Course and Prognosis
		Evaluation and Differential Diagnosis
		Treatment
	Elimination Disorders
		Functional Encopresis
		Functional Enuresis
	Selective Mutism
		Clinical Description
		Epidemiology
		Etiology
		Course and Prognosis
		Evaluation and Differential Diagnosis
		Treatment
	Reactive Attachment Disorder of Infancy or Early Childhood
		Clinical Description
		Epidemiology
		Etiology
		Course and Prognosis
		Evaluation
		Differential Diagnosis
		Treatment
	References
	Additional Reading
5 "Adult" Disorders That May Begin in Childhood or Adolescence
	Eating Disorders
		Anorexia Nervosa
		Bulimia Nervosa
	Substance-Related Disorders
		Clinical Description
		Epidemiology
		Comorbidity
		Etiology
		Course and Prognosis
		Evaluation and Differential Diagnosis
		Treatment
	Schizophrenia
		Clinical Description
		Epidemiology
		Etiology
		Course and Prognosis
		Evaluation and Differential Diagnosis
		Treatment
	Mood Disorders
		Clinical Description
		Epidemiology
		Etiology
		Course and Prognosis
		Evaluation and Differential Diagnosis
		Treatment
	Anxiety Disorders
		Specific Phobia and Social Phobia (Social Anxiety Disorder)
		Generalized Anxiety Disorder
		Posttraumatic Stress Disorder
		Obsessive-Compulsive Disorder
		Panic Disorder
	Gender Identity Disorder
		Clinical Description
		Epidemiology
		Etiology
		Course and Prognosis
		Evaluation and Differential Diagnosis
		Treatment
	Sleep Disorders
		Evaluation of Sleep-Related Complaints
		Dyssomnias
		Parasomnias
	Adjustment Disorders
		Clinical Description
		Epidemiology
		Etiology
		Course and Prognosis
		Evaluation and Differential Diagnosis
		Treatment
	References
	Additional Reading
6 Developmental Disorders
	Mental Retardation
		Clinical Description
		Epidemiology
		Comorbidity
		Etiology
		Course and Prognosis
		Evaluation and Differential Diagnosis
		Treatment
	Pervasive Developmental Disorders
		Autistic Disorder
		Asperger's Disorder
	Specific Developmental Disorders
		Epidemiology
		Etiology
		Learning Disorders
		Motor Skills Disorder: Developmental Coordination Disorder
		Communication Disorders
		Stuttering
	References
	Additional Reading
7 Special Clinical Circumstances
	Emergencies
		Assessment and Triage
		Suicide
		Child Maltreatment
		Out-of-Control Behavior
	Family Transitions
		Divorce
		Physical Illness in Parents or Siblings
		Death of a Family Member
		Adoption
		Working Parents
	Adolescent Pregnancy
		Demographics
		The Mother
		The Child
		Interventions
	Obesity
		Clinical Description
		Epidemiology
		Etiology
		Course and Prognosis
		Evaluation and Differential Diagnosis
		Treatment
	Physically Ill Children And Adolescents
		Developmental Factors in Reaction to Acute Illness, Hospitalization, and Surgery
		Chronic Illness
		Adherence to Treatment
		Treatment
	Children of Psychiatrically Ill Parents
		Risks and Resilience
		Interventions
	References
	Additional Reading
8 Psychopharmacology
	Special Issues for Children and Adolescents
		General Principles
		Developmental Toxicity
		Indications and Dosage
		Outcome
		Adherence to Treatment
		Ethical Issues
	Stimulants
		Indications and Efficacy
		Initiation and Ongoing Treatment
		Risks and Side Effects
	Atomoxetine
	Antidepressants
		Indications and Efficacy
		Initiation and Ongoing Treatment
		Risks and Side Effects
	Lithium Carbonate
		Indications and Efficacy
		Initiation and Ongoing Treatment
		Risks and Side Effects
	Antipsychotics
		Indications and Efficacy
		Initiation and Ongoing Treatment
		Risks and Side Effects
	Minor Tranquilizers, Sedatives, and Hypnotics
		Indications and Efficacy
		Initiation and Ongoing Treatment
		Risks and Side Effects
	Anticonvulsants
		Indications and Efficacy
		Initiation and Ongoing Treatment
		Risks and Side Effects
	Antihistamines
		Indications and Efficacy
		Initiation and Ongoing Treatment
		Risks and Side Effects
	Antiparkinsonian Agents
	Clonidine and Guanfacine
		Indications and Efficacy
		Initiation and Ongoing Treatment
		Risks and Side Effects
	Propranolol
		Indications and Efficacy
		Initiation and Ongoing Treatment
		Risks and Side Effects
	References
	Additional Reading
9 Psychosocial Treatments
	Communication With Children and Adolescents
	The Resistant Child or Adolescent
	Types of Individual Psychotherapy
		Supportive Therapy
		Psychodynamically Oriented Therapy
		Psychoanalysis
		Time-Limited Therapy
		Other Models of Therapy
	Parent Counseling and Psychoeducation
	Behavior Therapy
		Indications and Efficacy
		Parent Management Training
		Classroom Behavior Modification
	Family Treatment
		Role of the Family in Treatment
		Family Therapy
	Group Therapy
		Indications
		Technical Considerations
		Developmental Issues
	Wraparound Services
	Hospitalization and Residential Treatment
		Indications
		Components of Treatment
	Day Treatment
	Adjunctive Treatments
		Special Education Placements
		Recreation
		Foster Care
		Parent Support Groups
	References
	Additional Reading
Appendix: Resources for Parents
	Information on the Internet
	Books
Index
	A
	B
	C
	D
	E
	F
	G
	H
	I
	J
	K
	L
	M
	N
	O
	P
	Q
	R
	S
	T
	U
	V
	W
	X
	Y
	Z
                        
Document Text Contents
Page 2

CONCISE GUIDE TO

Child and Adolescent
Psychiatry

Third Edition

Page 203

This page intentionally left blank

Page 204

179

6

DEVELOPMENTAL
DISORDERS

The pervasive developmental disorders (PDDs), including autistic dis-
order, and specific developmental disorders are coded on DSM-IV-TR
(American Psychiatric Association 2000) Axis I. Mental retardation is
the only developmental disorder now coded on Axis II.

■ MENTAL RETARDATION

Clinical Description

The DSM-IV-TR diagnosis of mental retardation requires low intel-
ligence (IQ of approximately 70 or below), deficits in adaptive
functioning, and onset prior to age 18 years. Adaptive skills include
communication, self-care, home living, social skills, community re-
source use, self-direction, health and safety, functional academics,
leisure, and work. Clinical features vary according to the degree of
retardation (Table 6–1).

Epidemiology

Prevalence of mental retardation in the United States ranges from
1% to 3%, depending on the definition of adaptive functioning, and
is highest among school-age children. All levels of severity of men-
tal retardation are more common in males (overall, about 1.5:1).
Mental retardation secondary to biological factors is as common in
upper as in lower socioeconomic groups. When the etiology is not

Page 406

381

TRF. See Teacher Report Form
Tricyclic antidepressants (TCAs),

278
for attention-deficit/hyperactivity

disorder, 286
for bulimia nervosa, 117
for depression, 288
for enuresis, 288
guidelines for use, 287
initiation and ongoing

treatment, 285–288
for obsessive-compulsive

disorder, 286–287
risks and side effects, 290
for separation anxiety, 287–288
for separation anxiety disorder,

70
side effects, 117
toxicity, 291

Trifluoperazine (Stelazine), 295
for developmental disorders,

297
Trilafon. See Perphenazine
Tuberous sclerosis, 193
Twins, identical, in specific

developmental disorders,
198

U.S. Food and Drug
Administration (FDA), 260

Valium. See Diazepam
Valproate, for conduct disorder, 54
Valproic acid, 308

adverse effects, 309
Venlafaxine (Effexor), 280

Vineland Adaptive Behavior
Scales, 186, 18

Vistaril. See Hydroxyzine
Vomiting, with bulimia nervosa,

113

WAIS-III. See Wechsler Adult
Intelligence Scale—Third
Edition

Wechsler Adult Intelligence
Scale—Third Edition
(WAIS-III), 17

Wechsler Individual Achievement
Tests, Second Edition
(WIAT-II), 17

Wechsler Intelligence Scale for
Children—Third Edition
(WISC-III), 17

Wechsler Preschool and Primary
Scale of Intelligence—Third
Edition (WPPSI-III), 17

Weight gain
from antipsychotic

medications, 302
as treatment for anorexia

nervosa, 111
Wellbutrin. See Bupropion
WIAT-II. See Wechsler Individual

Achievement Tests, Second
Edition

Wide Range Achievement Test,
Third Edition (WRAT-3),
17

WISC-III. See Wechsler
Intelligence Scale for
Children—Third Edition

Page 407

382

WJ-R. See Woodcock-Johnson
Psychoeducational Battery—
Revised

Wolff-Parkinson-White syndrome,
285

Woodcock-Johnson
Psychoeducational Battery—
Revised (WJ-R), 17

WPPSI-III. See Wechsler
Preschool and Primary Scale
of Intelligence—Third
Edition

Wraparound services, 340

WRAT-3. See Wide Range
Achievement Test, Third
Edition

Xanax. See Alprazolam

Youth Risk Behavior Survey, 214
Youth Self-Report (YSR), 14
YSR. See Youth Self-Report

Zero to Three, 350
Ziprasidone (Geodon), 296

for Tourette’s disorder, 82
Zoloft. See Sertraline
Zyprexa. See Olanzapine

Similer Documents